Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607477 · ClinicalTrials.gov registry record · NA
Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00607477: Clinical Trial NA study, sponsored by University of Chicago.
NCT00607477 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00607477, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the length of time and extent of blood pressure response to minoxidil and hydralazine among cancer patients with difficult-to-treat vascular endothelial growth factor (VEGF) inhibitor treatment induced hypertension.
Interventions
- DRUG Minoxidil
- DRUG Hydralazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-01 |
| Phase | NA |
Why NCT00607477 stopped before completion
NCT00607477 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Minoxidil is the first listed.
NCT00607477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00607477 about?
NCT00607477 is a clinical study titled "Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension". The purpose of this study is to describe the length of time and extent of blood pressure response to minoxidil and hydralazine among cancer patients with difficult-to-treat vascular endothelial growth factor (VEGF) inhibitor treatment induced hypertension.
What is the current status of trial NCT00607477?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2008-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00607477?
The interventions under investigation include: Minoxidil (DRUG), Hydralazine (DRUG).
Who is sponsoring clinical trial NCT00607477?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00607477's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia